Last updated: 11th May, 2021

SeptiCyte® RAPID revolutionizes sepsis diagnosis and treatment, with actionable results available in an hour. SeptiCyte®RAPID can determine the likelihood of sepsis and differentiate from non-infectious systemic inflammatory response syndrome (SIRS) in critically ill patients. The test, which uses a small volume of blood, can be performed easily in any hospital lab with the Biocartis Idylla™ molecular testing system. SeptiCyte®RAPID is available for IVD use in New Zealand and RUO in Australia.

Request a Quote

Request Quote

Go BackGo Back